Repurposing of Doramectin as a New Anti-Zika Virus Agent.

Repurposing of Doramectin as a New Anti-Zika Virus Agent.
复制标题

将多拉摄影素的再利用为一种新的抗Zika病毒剂。

DOI:
10.3390/v15051068
复制
发表时间:
2023-04-27
期刊:
Viruses
影响因子:
--
通讯作者:
Yuan J
Yuan J
中科院分区:
其他
文献类型:
--
作者:
Zhu Y;Liang M;Yu J;Zhang B;Zhu G;Huang Y;He Z;Yuan J

文献摘要

参考文献

相似文献

寨卡病毒(ZIKV)属于黄病毒科,主要由蚊子传播,可导致多种不良后果,包括格林-巴利综合征、小头畸形和脑膜脑炎。然而,没有批准的疫苗或药物可用于ZIKV。ZIKV药物的发现和研究仍然是必不可少的。在这项研究中,我们确定多拉菌素(一种批准的兽用抗寄生虫药物)是一种新型抗ZIKV药物(EC 50值为0.85 μM至3.00 μM),在多种细胞模型中具有低细胞毒性(CC 50> 50 μM)。在多拉菌素处理下,ZIKV蛋白的表达也显著降低。进一步研究表明,多拉菌素与ZIKV基因组复制的关键酶RNA依赖性RNA聚合酶(RdRp)直接相互作用,亲和力更强(Kd = 16.9 μM),可能与影响ZIKV复制有关。这些结果表明,多拉菌素可能是一种有前途的抗ZIKV候选药物。
Zika virus (ZIKV), belonging to the Flavivirus family and mainly transmitted by mosquitoes, causes a variety of adverse outcomes, including Guillain-Barré syndrome, microcephaly, and meningoencephalitis. However, there are no approved vaccines or drugs available for ZIKV. The discovery and research on drugs for ZIKV are still essential. In this study, we identified doramectin, an approved veterinary antiparasitic drug, as a novel anti-ZIKV agent (EC50 value from 0.85 μM to 3.00 μM) with low cytotoxicity (CC50 > 50 μM) in multiple cellular models. The expression of ZIKV proteins also decreased significantly under the treatment of doramectin. Further study showed that doramectin directly interacted with the key enzyme for ZIKV genome replication, RNA-dependent RNA polymerase (RdRp), with a stronger affinity (Kd = 16.9 μM), which may be related to the effect on ZIKV replication. These results suggested that doramectin might serve as a promising drug candidate for anti-ZIKV.
DOI: 10.1056/nejmoa1602412
发表时间: 2016-12-15
期刊: The New England journal of medicine
影响因子: --
作者:
Brasil P;Pereira JP Jr;Moreira ME;Ribeiro Nogueira RM;Damasceno L;Wakimoto M;Rabello RS;Valderramos SG;Halai UA;Salles TS;Zin AA;Horovitz D;Daltro P;Boechat M;Raja Gabaglia C;Carvalho de Sequeira P;Pilotto JH;Medialdea-Carrera R;Cotrim da Cunha D;Abreu de Carvalho LM;Pone M;Machado Siqueira A;Calvet GA;Rodrigues Baião AE;Neves ES;Nassar de Carvalho PR;Hasue RH;Marschik PB;Einspieler C;Janzen C;Cherry JD;Bispo de Filippis AM;Nielsen-Saines K
通讯作者: Nielsen-Saines K
DOI: 10.1016/j.antiviral.2017.08.007
发表时间: 2017-10
期刊: Antiviral research
影响因子: 7.6
作者:
Kamiyama N;Soma R;Hidano S;Watanabe K;Umekita H;Fukuda C;Noguchi K;Gendo Y;Ozaki T;Sonoda A;Sachi N;Runtuwene LR;Miura Y;Matsubara E;Tajima S;Takasaki T;Eshita Y;Kobayashi T
通讯作者: Kobayashi T
DOI: 10.3892/ijo.2022.5319
发表时间: 2022-03-01
影响因子: 5.2
作者:
Chen, Chen;Liang, Hongsheng;Gao, Aili
通讯作者: Gao, Aili
Zika NS1 诱导的 ER 重塑对于病毒复制至关重要
DOI: 10.1083/jcb.201903062
发表时间: 2020-02-03
影响因子: 7.8
作者:
Ci, Yali;Liu, Zhong-Yu;Shi, Lei
通讯作者: Shi, Lei
DOI: 10.1093/jac/dks147
发表时间: 2012-08-01
影响因子: 5.2
作者:
Mastrangelo, Eloise;Pezzullo, Margherita;Milani, Mario
通讯作者: Milani, Mario